These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 6493580

  • 1. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG, Midtvedt T, Dahl O.
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [Abstract] [Full Text] [Related]

  • 2. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC, Gavan TL, Gerlach EH, Jones RN, Barry AL, Thornsberry C.
    Am J Med Sci; 1977 Jun; 274(3):255-63. PubMed ID: 610415
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG, Midtvedt T, Dahl O.
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [Abstract] [Full Text] [Related]

  • 4. [Antibacterial spectrum of mezlocillin and MIC/disc correlations (author's transl)].
    Soussy CJ, Le Van Thoi J, Duval J.
    Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):309-13. PubMed ID: 6460965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX, Jules K, Neu HC.
    Eur J Clin Microbiol; 1986 Feb 04; 5(1):23-8. PubMed ID: 2938945
    [Abstract] [Full Text] [Related]

  • 9. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C, Sageaux JC, Bebear C, Latrille J.
    Pathol Biol (Paris); 1983 Jun 04; 31(6):463-6. PubMed ID: 6224123
    [Abstract] [Full Text] [Related]

  • 10. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
    Brun Y, Forey F, Coulet M, Fleurette J, Bryskier A.
    Pathol Biol (Paris); 1983 May 04; 31(5):343-6. PubMed ID: 6312394
    [Abstract] [Full Text] [Related]

  • 11. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL, Drugeon HB, Bryskier A, Chung SS, Reynaud A.
    Pathol Biol (Paris); 1982 Jun 04; 30(6):432-9. PubMed ID: 6810287
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E, Mark Z, Samra Y, Alkan M, Berger S.
    Chemioterapia; 1986 Apr 04; 5(2):75-82. PubMed ID: 2939966
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R, Waldvogel FA.
    Clin Ther; 1980 Apr 04; 3(Spec Issue):89-97. PubMed ID: 6446401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
    López-Brea M, Alarcón T, Domingo D, Díaz-Regañón J.
    J Antimicrob Chemother; 2008 Jan 04; 61(1):139-42. PubMed ID: 17965421
    [Abstract] [Full Text] [Related]

  • 17. The in-vitro activity of azlocillin: a community hospital study of 1900 clinical isolates.
    Parry MF.
    J Antimicrob Chemother; 1983 May 04; 11 Suppl B():15-20. PubMed ID: 6619025
    [Abstract] [Full Text] [Related]

  • 18. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD, Levison ME, Kaye D.
    Infection; 1980 May 04; 8(3):121-2. PubMed ID: 6448229
    [Abstract] [Full Text] [Related]

  • 19. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun 04; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 20. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 May 04; 58(1):19-26. PubMed ID: 17383139
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.